Fidelity Investments’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.2K | Buy |
3,077
+2,110
| +218% | +$18.7K | ﹤0.01% | 4164 |
|
|
2025
Q1 | $10.4K | Buy |
967
+162
| +20% | +$1.74K | ﹤0.01% | 4480 |
|
|
2024
Q4 | $10.3K | Sell |
805
-50,424
| -98% | -$645K | ﹤0.01% | 4456 |
|
|
2024
Q3 | $1.41M | Sell |
51,229
-85,444
| -63% | -$2.36M | ﹤0.01% | 2502 |
|
|
2024
Q2 | $3.96M | Sell |
136,673
-1,790
| -1% | -$51.9K | ﹤0.01% | 2150 |
|
|
2024
Q1 | $6.18M | Sell |
138,463
-973
| -0.7% | -$43.4K | ﹤0.01% | 2024 |
|
|
2023
Q4 | $5.41M | Sell |
139,436
-2,935
| -2% | -$114K | ﹤0.01% | 2038 |
|
|
2023
Q3 | $4.19M | Sell |
142,371
-851
| -0.6% | -$25K | ﹤0.01% | 2092 |
|
|
2023
Q2 | $9.11M | Sell |
143,222
-3,288
| -2% | -$209K | ﹤0.01% | 1897 |
|
|
2023
Q1 | $6.92M | Sell |
146,510
-2,059
| -1% | -$97.2K | ﹤0.01% | 2002 |
|
|
2022
Q4 | $10.3M | Sell |
148,569
-16,162
| -10% | -$1.12M | ﹤0.01% | 1873 |
|
|
2022
Q3 | $24.2M | Buy |
164,731
+24,654
| +18% | +$3.61M | ﹤0.01% | 1549 |
|
|
2022
Q2 | $18.3M | Buy |
140,077
+15,961
| +13% | +$2.08M | ﹤0.01% | 1687 |
|
|
2022
Q1 | $12.5M | Buy |
124,116
+70,993
| +134% | +$7.17M | ﹤0.01% | 2023 |
|
|
2021
Q4 | $8.22M | Buy |
53,123
+34,158
| +180% | +$5.29M | ﹤0.01% | 2194 |
|
|
2021
Q3 | $5.61M | Buy |
18,965
+6,605
| +53% | +$1.96M | ﹤0.01% | 2325 |
|
|
2021
Q2 | $4.02M | Buy |
+12,360
| New | +$4.02M | ﹤0.01% | 2398 |
|